

The E4 type of ApoE is relatively common, with about 30-55% of people with two E4 copies expected to develop symptoms of mild cognitive impairment or dementia due to Alzheimer's disease. However, it is important to remember that having two E4 copies does not guarantee that someone will develop symptoms, and that other factors can also contribute to the risk of developing Alzheimer's disease.